Built on MVE’s legacy SC 4/2V and 4/3V vapor shipper platform, the next-generation SC 4/2V and 4/3V models have been ...

Dr. Richard Philipson has been appointed Chief Medical Officer (CMO) of Hansa Biopharma AB, effective July 14.

Celltrion USA announced that Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo), biosimilars referencing Prolia ...

Centauri Therapeutics Limited, an immunotherapy company, has appointed Dr. Debra Barker as Chief Medical Officer (CMO).

Almac Clinical Services has completed a multi-million-dollar investment to enhance cold chain capabilities at its global ...

Natoli Engineering's Precision CT Scan allows manufacturers to visualize internal tablet structures without cutting or ...

Axplora has announced a transformative €35 million ($41.2 million) expansion at its Farmabios site in Gropello Cairoli, Italy ...

Pace Life Sciences LLC is remodeling and expanding its Salem, NH, site to establish a Center of Excellence for Aseptic ...

Körber’s Business Area Pharma now offers a standardized approach to connect systems and equipment to its market-leading PAS-X ...

Circio Holding ASA, a biotechnology company developing circular RNA technology for next generation nucleic acid medicine, has ...

The CDMO has increased its capacity by acquiring and installing a new, fully Annex 1 compliant, sterile filling line. As a ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Fujifilm’s FF-10832, an investigational liposomal formulation of gemcitabine, for the treatment of biliary tract ...